Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
- BPC 157 Banned: Key Facts on the Latest FDA Decision - Download Now
The peptide stimulates production of VEGF (vascular endothelial growth factor) and HGF (hepatocyte growth factor), both critical for building new capillary networks
Preclinical models report accelerated structural restoration following peptide exposure, characterized by increased fibroblast proliferation, enhanced extracellular matrix organization, and improved collagen deposition
This mechanism also improves insulin sensitivity and modulates energy homeostasis, contributing to fat loss and preservation of muscle mass during caloric restriction
During pregnancy there is no increased rate of birth defects, but low birth weight and premature birth have been linked to cyclosporine use
Triple agonist (GIP/GLP-1/Glucagon) for advanced metabolic research
US$ 29.41
US$ 28.73
US$ 22.86
US$ 20.36
US$ 29.60
